trial · primary record
PGT121.414.LS
HIV-1
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2029-05-31 |
| Primary endpoint | Proportion of infants with at least one Grade 3 or higher Adverse Event (AE) (one dose) |
| Registry ID | NCT06517693 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:42.632Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06517693
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.